Emulsified Densiron may have contributed to significant intraocular inflammation, ERM formation, and CMO. This has potentially significant implications on the indications for Densiron-68 use.
AC inflammation with fibrin accumulation (41%) Sterile hypopyon (1%) PC inflammation with preretinal membranes without traction (0.3%) Hyphema and endothelial corneal dystrophy (1%) Rise in IOP (25%) Emulsification with pseudohypopyon (1%)
Special attention must be paid to unusual adverse effects like inflammatory reactions and fibrin accumulation in the anterior chamber.
Histopathological analysis showed that the structure and associated inflammatory response of membranes were similar to those observed following the use of conventional oils
Mild-to-moderate AC inflammation (45%) Fibrin accumulation (40%) Temporary pupillary synechiae (15%) Rise in IOP (17.5%) Emulsification and dispersion (22.5%) Cataract progression (77.8%) ERM (30%)
Oxane HD showed an encouraging anatomical and functional success rate and good intraocular tolerance, with a few complications in complicated RD patients
Mild-to-moderate AC inflammation (24%) Severe intraocular inflammatory reaction (10%) Emulsification (24%) and pseudohypopyon (10%) Early posterior capsular cataract (24%) Choroidal detachment/ocular hypotension (5%) Rise in IOP (20%) Pupillary block (5%) Transient corneal edema (5%)
Vitreoretinal surgery with temporary Densiron 68 intraocular tamponade appears to increase anatomical success, while giving rise to minimal complications, in selected cases of complicated RD and PVR
Posterior capsular opacification (22%) Severe intraocular inflammation (6%) Pseudohypopyon (6%) Emulsification (33%) Rise in IOP (11%) ERM (28%)
The relatively high rate of emulsification and increased risk of intraocular complication when compared to other reported series is less promising and warrants further evaluation
Emulsification in AC (19%) Mild/severe intraocular inflammation (9.6%) Cataract formation (71%) Sticky oil formation (9.6%) Posterior synechiae (3.2%)
HeavySil is a safe and effective tamponade agent for the treatment of complicated RD; no major complication in terms of corneal damage, hypotension or hypertension, or postoperative proliferation was observed